218 related articles for article (PubMed ID: 12764404)
41. Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1.
Tanaka Y; Daida H; Imai Y; Miyauchi K; Sato Y; Hiwatari M; Kitagawa A; Kishimoto J; Yamazaki T; Kawamori R
Hypertens Res; 2009 Sep; 32(9):770-4. PubMed ID: 19557003
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
Hashimoto J; Hirayama H; Hanasawa T; Watabe D; Asayama K; Metoki H; Kikuya M; Ohkubo T; Totsune K; Imai Y
Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
[TBL] [Abstract][Full Text] [Related]
43. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
van den Meiracker AH; Baggen RG; Pauli S; Lindemans A; Vulto AG; Poldermans D; Boomsma F
J Hypertens; 2006 Nov; 24(11):2285-92. PubMed ID: 17053552
[TBL] [Abstract][Full Text] [Related]
44. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
Akram J; Sheikh UE; Mahmood M; Donnelly R
Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
[TBL] [Abstract][Full Text] [Related]
45. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
Fogari R; Derosa G; Zoppi A; Rinaldi A; Preti P; Lazzari P; Mugellini A
Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
[TBL] [Abstract][Full Text] [Related]
46. Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa.
Marre M; Lièvre M; Vasmant D; Gallois Y; Hadjadj S; Reglier JC; Chatellier G; Mann J; Viberti GC; Passa P
Diabetes Care; 2000 Apr; 23 Suppl 2():B40-8. PubMed ID: 10860190
[TBL] [Abstract][Full Text] [Related]
47. [Hypertension, insulin resistance and diabetes mellitus: pathophysiological interactions and therapeutic consequences].
Schernthaner G
Wien Klin Wochenschr; 1990 Dec; 102(24):707-12. PubMed ID: 1980767
[TBL] [Abstract][Full Text] [Related]
48. Long-term persistence with antihypertensive drugs in new patients.
Degli Esposti E; Sturani A; Di Martino M; Falasca P; Novi MV; Baio G; Buda S; Volpe M
J Hum Hypertens; 2002 Jun; 16(6):439-44. PubMed ID: 12037702
[TBL] [Abstract][Full Text] [Related]
49. [How to use anti-hypertensive medication in management of diabetic patients].
Hirose H; Saito I
Nihon Rinsho; 2003 Jul; 61(7):1205-9. PubMed ID: 12877086
[TBL] [Abstract][Full Text] [Related]
50. Trends in antihypertensive drug use among orally treated diabetic patients, in France between 1981 and 1992. Impact of guidelines and new drugs.
Maison P; Planchat-Fely P; Vauzelle-Kervroëdan F; Sermet C; Eschwège E
Diabetes Metab; 2001 Dec; 27(6):661-5. PubMed ID: 11852374
[TBL] [Abstract][Full Text] [Related]
51. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus.
Kim ES; Kwon HS; Ahn CW; Lim DJ; Shin JA; Lee SH; Cho JH; Yoon KH; Kang MI; Cha BY; Son HY
J Diabetes Complications; 2011; 25(5):309-13. PubMed ID: 21130003
[TBL] [Abstract][Full Text] [Related]
52. Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort.
Hellemons ME; Denig P; de Zeeuw D; Voorham J; Lambers Heerspink HJ
Nephrol Dial Transplant; 2013 Mar; 28(3):706-15. PubMed ID: 23262433
[TBL] [Abstract][Full Text] [Related]
53. Awareness of albuminuria in an Italian population-based cohort of patients treated with hypoglycemic drugs.
Degli Esposti L; Saragoni S; Buda S; Sturani A; Quintaliani G; Bartolucci S; Di Turi R; Lilli P; Didoni G; Degli Esposti E
J Nephrol; 2012; 25(3):325-31. PubMed ID: 21748718
[TBL] [Abstract][Full Text] [Related]
54. [Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects].
Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
Przegl Lek; 2001; 58(3):124-6. PubMed ID: 11475857
[TBL] [Abstract][Full Text] [Related]
55. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
Nosadini R; Tonolo G
J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
[TBL] [Abstract][Full Text] [Related]
56. Management of hypertension in diabetes.
Arauz-Pacheco C; Raskin P
Endocrinol Metab Clin North Am; 1992 Jun; 21(2):371-94. PubMed ID: 1612071
[TBL] [Abstract][Full Text] [Related]
57. Persistent microalbuminuria after treatment with renin-angiotensin axis blockers: causes and results of treatment intensification.
Robles NR; Velasco J; Espinosa J; Mena C; Angulo E;
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):333-9. PubMed ID: 20647247
[TBL] [Abstract][Full Text] [Related]
58. Dihydropyridine calcium antagonists are associated with increased albuminuria in treatment-resistant hypertensives.
Hummel D; Raff U; Schwarz TK; Schneider MP; Schmieder RE; Schmidt BM
J Nephrol; 2010; 23(5):563-8. PubMed ID: 20437398
[TBL] [Abstract][Full Text] [Related]
59. Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden.
Nilsson PM; Gudbjörnsdottir S; Eliasson B; Cederholm J;
J Hum Hypertens; 2003 Jan; 17(1):37-44. PubMed ID: 12571615
[TBL] [Abstract][Full Text] [Related]
60. [Hypertension associated with diabetes: inquiry into the attitudes and behaviors of French physicians].
Passa P; Mallion JM; Vasmant D; Saint-Paul D; Dreyfus JP; Tordjman E; Doan Tran D
Diabete Metab; 1992; 18(2 Pt 2):170-81. PubMed ID: 1639205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
